The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

[1]  P. Cheah,et al.  Human Gene Mutations , 1998, Human Genetics.

[2]  Polly Matzinger,et al.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.

[3]  Richard A. Flavell,et al.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.

[4]  Stephen P. Schoenberger,et al.  T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.

[5]  M. Clerici,et al.  Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. , 1998, Journal of immunology.

[6]  J. Hartwig,et al.  WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Cocks,et al.  Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. , 1997, Journal of immunology.

[8]  J. Redondo,et al.  Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells , 1997, Molecular and cellular biology.

[9]  L. Varticovski,et al.  Tyrosine Phosphorylation of the CD3-ε Subunit of the T Cell Antigen Receptor Mediates Enhanced Association with Phosphatidylinositol 3-Kinase in Jurkat T Cells* , 1997, The Journal of Biological Chemistry.

[10]  B. Cocks,et al.  Increased expression of signaling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium. , 1997, Journal of immunology.

[11]  B. Cocks,et al.  Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. , 1997, Journal of immunology.

[12]  B. Cocks,et al.  SLAM and its role in T cell activation and Th cell responses , 1997, Immunology and cell biology.

[13]  B. Cocks,et al.  Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes , 1997, The Journal of experimental medicine.

[14]  B. Trask,et al.  A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. , 1997, Genomics.

[15]  D. Schlessinger,et al.  4.5-Mb YAC STS contig at 50-kb resolution, spanning Xq25 deletions in two patients with lymphoproliferative syndrome. , 1997, Genome research.

[16]  R. Sékaly,et al.  An Epstein-Barr virus-associated superantigen , 1996, The Journal of experimental medicine.

[17]  T. Mak,et al.  Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4 , 1996, Science.

[18]  D. Schlessinger,et al.  Physical Map and Cosmid Contig Encompassing a New Interstitial Deletion of the X-Linked Lymphoproliferative Syndrome Region , 1996, European journal of human genetics : EJHG.

[19]  Jack R. Davis,et al.  X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery , 1995, Pediatric Research.

[20]  B. Cocks,et al.  A novel receptor involved in T-cell activation , 1995, Nature.

[21]  C. Levelt,et al.  Over-expression of CD3ε transgenes blocks T lymphocyte development , 1995 .

[22]  M. Roncarolo,et al.  Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity. , 1986, Clinical and experimental immunology.

[23]  D. Purtilo,et al.  Immunopathology of X-linked lymphoproliferative syndrome. , 1983, Immunology today.